---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-264072"
form_type: "8-K"
ticker: "RMD"
cik: "0000943819"
company_name: "RESMED INC"
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T09:31:41.389148+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ResMed Q1 FY2024 revenue up 16% to $1.10B; non-GAAP EPS $1.64 (+9% YoY)

## Summary
- Revenue $1,102.3M (+16% YoY); operating income $289.0M (+5%); non-GAAP operating profit +10%.
- Diluted EPS $1.49 (GAAP) and $1.64 (non-GAAP, +9% YoY); gross margin 54.4%, down 250 bps.
- Operating cash flow $286.3M; company expects to resume share repurchase program in upcoming quarter.
- Board declared quarterly dividend of $0.48/share, payable Dec 14, record Nov 9.

## SEC filing metadata
- accession: 0001193125-23-264072
- form_type: 8-K
- ticker: RMD
- cik: 0000943819
- company_name: RESMED INC
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/0001193125-23-264072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/d547248d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-264072
- JSON: https://secwatch.observer/filing/0001193125-23-264072.json
- Plain text: https://secwatch.observer/filing/0001193125-23-264072.txt

## Key facts
- Earnings Releases
  RESMED INC reported financial results for the quarter ended September 30, 2023.
  - Period: the quarter ended September 30, 2023
  - Result: reported results
  source text: On October 26, 2023, we issued the press release furnished as Exhibit 99.1. The press release describes the results of our operations for the quarter ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/943819/000119312523264072/0001193125-23-264072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.